Eisai eyes long game for Leqembi amid ‘dramatically’ increasing patient usenews2023-11-07T19:03:14+00:00November 7th, 2023|Endpoints News|
Senate confirms Monica Bertagnolli to lead NIH with bipartisan 62-36 votenews2023-11-07T18:40:27+00:00November 7th, 2023|Endpoints News|
French authorities investigate Sanofi over market manipulation, misleading financial communicationsnews2023-11-07T18:40:00+00:00November 7th, 2023|Endpoints News|
FTC challenges more than 100 drug patents owned by AbbVie, AstraZeneca, Boehringer and seven othersnews2023-11-07T17:47:36+00:00November 7th, 2023|Endpoints News|
Imbria touts PhII success in hypertrophic cardiomyopathy, adding fuel to overall efficacy profilenews2023-11-07T16:29:32+00:00November 7th, 2023|Endpoints News|
Sage’s PPD drug to cost $15K; Abcam shareholders vote ‘yes’ on Danaher dealnews2023-11-07T15:35:48+00:00November 7th, 2023|Endpoints News|
MarketingRx roundup: Sanofi, Regeneron renew Dupixent asthma effort; Bausch Health battles seasonal affective disordernews2023-11-07T15:29:00+00:00November 7th, 2023|Endpoints News|
mRNA’s next trick? Reprogramming off-the-shelf cell therapies for cancer and autoimmune diseasesnews2023-11-07T15:23:49+00:00November 7th, 2023|Endpoints News|
Pfizer gathers Covid campaign ‘icons’ Martha Stewart, John Legend, Travis Kelce and more for latest booster pushnews2023-11-07T15:22:11+00:00November 7th, 2023|Endpoints News|
WuXi XDC eyes IPO to boost ADC, bioconjugate manufacturing footprintnews2023-11-07T13:56:19+00:00November 7th, 2023|Endpoints News|
